Showing 1 - 10 of 30
Persistent link: https://www.econbiz.de/10003050690
Artemisinin-based combination treatments (ACTs) are seen as an important tool in the global effort to roll back malaria. With rapidly increasing parasite resistance to chloroquine in many parts of the world, there is greater international recognition of the need for both a different antimalarial...
Persistent link: https://www.econbiz.de/10012554129
We consider a health authority seeking to allocate annual budgets optimally over time to minimize the discounted social cost of infection(s) evolving in a finite set of "R greater than or equal to 2" groups. This optimization problem is challenging, since as is well known, the standard...
Persistent link: https://www.econbiz.de/10013147229
We use analytical and numerical models to explain and quantify the welfare effects of subsidies for artemisinin combination treatments (ACTs), a valuable new class of antimalarial drugs. There are two (second-best) efficiency rationales for such subsidies: by expanding drug use, they reduce...
Persistent link: https://www.econbiz.de/10014055265
Artemisinin-based combination treatments (ACTs) are seen as an important tool in the global effort to roll back malaria. With rapidly increasing parasite resistance to chloroquine in many parts of the world, there is greater international recognition of the need for both a different antimalarial...
Persistent link: https://www.econbiz.de/10014063296
We consider a health authority seeking to allocate annual budgets optimally over time to minimize the discounted social cost of infection(s) evolving in a finite set of R = 2 groups. This optimization problem is challenging, since as is well known, the standard epidemiological model describing...
Persistent link: https://www.econbiz.de/10008543806
We use analytical and numerical models to explain and quantify the welfare effects of subsidies for artemisinin combination treatments (ACTs), a valuable new class of antimalarial drugs. There are two (second-best) efficiency rationales for such subsidies: by expanding drug use, they reduce...
Persistent link: https://www.econbiz.de/10005442348
We consider a health authority seeking to allocate annual budgets optimally over time to minimize the discounted social cost of infection(s) evolving in a finite set of "R greater than or equal to 2" groups. This optimization problem is challenging, since as is well known, the standard...
Persistent link: https://www.econbiz.de/10008602818
Artemisinin-based combination treatments (ACTs) are seen as an important tool in the global effort to roll back malaria. With rapidly increasing parasite resistance to chloroquine in many parts of the world, there is greater international recognition of the need for both a different antimalarial...
Persistent link: https://www.econbiz.de/10005116470
Myriad policy measures aim to reduce greenhouse gas emissions from the electricity sector, promote generation from renewable sources, and encourage energy conservation. To what extent do innovation and energy efficiency (EE) market failures justify additional interventions when a carbon price is...
Persistent link: https://www.econbiz.de/10010352376